Galectin Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Galectin Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Galectin Therapeutics Inc
Rating: 0.71800
Author: Trendlyne DVM scores

about

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (G...

2.37 0.14 (6.28%)

66.76% Fall from 52W High

117.3K

XNAS Volume

XNAS 14 May, 2026 12:10 PM (EDT)

Board Meeting

The next board meeting for Galectin Therapeutics Inc is on 15 May 2026 for the purpose of Galectin Therapeutics Inc First Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

0.0 / 100

Technically Bearish

28.7 / 100

No estimates available

Galectin Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Galectin Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (G...

66.76% Fall from 52W High

SWOT Analysis

Galectin Therapeutics Inc Live Price Chart